Literature DB >> 15087428

The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.

Jun Kamegai1, Hideki Tamura, Takako Shimizu, Shinya Ishii, Atsushi Tatsuguchi, Hitoshi Sugihara, Shinichi Oikawa, Rhonda D Kineman.   

Abstract

Ghrelin is a GH-releasing peptide originally purified from the rat stomach. It has been demonstrated that ghrelin expression, within the gastroenteric system, is regulated by both the metabolic and GH milieu. Our laboratory and others have previously reported that ghrelin is also produced in the pituitary. Given that the receptor for ghrelin [GH secretagogue receptor (GHS-R)] is also expressed by the pituitary, the possibility exists that locally produced ghrelin plays an autocrine/paracrine role in regulating GH release. Because we have previously reported that GHRH infusion increases pituitary levels of ghrelin mRNA, we hypothesized that GHRH could be a key regulator of pituitary ghrelin expression. In this report, we demonstrate that 4-h GHRH infusion increased pituitary ghrelin peptide content. Interestingly, under experimental conditions in which hypothalamic GHRH expression is increased, e.g. GH deficiency due to GH gene mutation, glucocorticoid deficiency, and hypothyroidism, we observed that pituitary ghrelin expression (mRNA levels and peptide content) was also increased. Consistent with this positive correlation between GHRH and ghrelin, pituitary ghrelin expression (mRNA levels and peptide content) was found to be decreased in conditions in which hypothalamic GHRH expression is decreased, e.g. GH treatment, glucocorticoid excess, hyperthyroid state, and food deprivation. Collectively, these results suggest that pituitary ghrelin expression is GHRH dependent. We also conducted functional studies to examine whether the pituitary ghrelin/GHS-R system contributes to GH release after GHRH stimulation, by challenging pituitary cell cultures with GHRH in the presence of a GHS-R-specific inhibitor ([d-Lys-3]-GHRP-6). The GHS-R inhibitor did not affect GH release in the absence of GHRH, but significantly reduced GHRH-mediated GH release. This is the first report demonstrating that endogenous pituitary ghrelin can play a physiological role in GH release, by optimizing somatotroph responsiveness to GHRH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087428     DOI: 10.1210/en.2003-1424

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Ghrelin protected neonatal rat cardiomyocyte against hypoxia/reoxygenation injury by inhibiting apoptosis through Akt-mTOR signal.

Authors:  Lifeng Wang; Yingjie Lu; Xian Liu; Xiaoyun Wang
Journal:  Mol Biol Rep       Date:  2017-03-09       Impact factor: 2.316

3.  Ghrelin restoration of function in vitro in somatotropes from male mice lacking the Janus kinase (JAK)-binding site of the leptin receptor.

Authors:  Mohsin Syed; Michael Cozart; Anessa C Haney; Noor Akhter; Angela K Odle; Melody Allensworth-James; Christopher Crane; Farhan M Syed; Gwen V Childs
Journal:  Endocrinology       Date:  2013-02-15       Impact factor: 4.736

4.  GHRP-6 induces CREB phosphorylation and growth hormone secretion via a protein kinase Csigma-dependent pathway in GH3 cells.

Authors:  Chunlei Tian; Fei Ye; Tongjiang Xu; Sheng Wang; Xiaodan Wang; Heping Wang; Feng Wan; Ting Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

Review 5.  Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Authors:  Raul M Luque; Manuel D Gahete; Jose Cordoba-Chacon; Gwen V Childs; Rhonda D Kineman
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

6.  Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathways.

Authors:  Xue Feng Han; Yun Long Zhu; Maria Hernandez; Damien J Keating; Chen Chen
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

7.  Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.

Authors:  Patricia Molica; Sergio Oliva Nascif; Silvia Regina Correa-Silva; Larissa Bianca Paiva Cunha de Sá; José Gilberto Henriques Vieira; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

8.  Ghrelin and cardiovascular diseases.

Authors:  Gaigai Zhang; Xinhua Yin; Yongfen Qi; Lakshmana Pendyala; Jack Chen; Dongming Hou; Chaoshu Tang
Journal:  Curr Cardiol Rev       Date:  2010-02

9.  Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.

Authors:  Sergio Oliva Nascif; Silvia Regina Correa-Silva; Marcos Roberto Silva; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

10.  Brain transcriptome profile after CRISPR-induced ghrelin mutations in zebrafish.

Authors:  Ayelén Melisa Blanco; Raúl Cortés; Juan Ignacio Bertucci; Lucia Soletto; Elisa Sánchez; Ana Isabel Valenciano; José Miguel Cerdá-Reverter; María Jesús Delgado
Journal:  Fish Physiol Biochem       Date:  2019-10-30       Impact factor: 2.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.